In addition, PODXL overexpression activates CD16, a receptor involved in antibody-dependent cell cytotoxicity (ADCC), suggesting that PODXL may aid in tumour protection by impairing NK cell-mediated ADCC [17]. Here, PODXL is linked to neoplasm.